We are live on
!
Find out more
CSCI
COSCIENS Biopharma Inc. Common Stock
CSCI
CSCI
Delisted
CSCI was delisted on the 3rd of September, 2025.
12 hedge funds and large institutions have $95.7K invested in COSCIENS Biopharma Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
0.05% more ownership
Funds ownership: 0.22% → 0.27% (+0.05%)
9% less capital invested
Capital invested by funds: $106K → $95.7K (-$9.91K)
14% less funds holding
Funds holding: 14 → 12 (-2)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
92% less call options, than puts
Call options by funds: $35K | Put options by funds: $412K
Holders
12
Holders Change
-2
Holders Change %
-14.29%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
3
Closed
3
Calls
$35K
Puts
$412K
Net Calls
-$377K
Net Calls Change
+$114K
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$29.7K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$18.5K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$59 |
